Home / Health / Centre places purchase order with Serum for 660 mn Covishield doses: Report

Centre places purchase order with Serum for 660 mn Covishield doses: Report

The Pune-based firm has enhanced the manufacturing capacity of Covishield to more than 200 mn doses per month.

India too had opened diplomatic dialogues with the European Union (EU) after the EU Digital Covid Certificate framework recognised the AstraZeneca-Oxford vaccine, but not Covishield.

Premium

3 min read Last Updated : Sep 09 2021 | 7:26 PM IST

The Union government has placed a purchase order with the Serum Institute of India (SII) for 66 crore doses of Covishield to be supplied by December, official sources said on Thursday.

The development comes after Prakash Kumar Singh, the Director, Government and Regulatory Affairs at SII, informed the Union Health Ministry that the firm would be able to supply 20.29 crore doses of Covishied in the month of September.

The Pune-based firm has enhanced the manufacturing capacity of Covishield to more than 20 crore doses per month.

The Health Ministry had in July placed an order with Bharat Biotech for

Disclaimer: No Business Standard Journalist was involved in creation of this content

Topics : Coronavirus Centre Coronavirus Vaccine

What you get on BS Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.

VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in